Drug Information

Drug General Information
Drug ID
D0S4DV
Former ID
DNC014836
Drug Name
CALYSTEGINE B2
Drug Type
Small molecular drug
Indication Discovery agent Investigative [551364]
Formula
C7H13NO4
Canonical SMILES
C1CC2(C(C(C(C1N2)O)O)O)O
InChI
1S/C7H13NO4/c9-4-3-1-2-7(12,8-3)6(11)5(4)10/h3-6,8-12H,1-2H2/t3-,4+,5-,6+,7-/m1/s1
InChIKey
FXFBVZOJVHCEDO-IBISWUOJSA-N
PubChem Compound ID
124434
Target and Pathway
Target(s) Alpha-galactosidase A Target Info Inhibitor [551364]
KEGG Pathway Galactose metabolism
Glycerolipid metabolism
Sphingolipid metabolism
Glycosphingolipid biosynthesis - globo series
Lysosome
PathWhiz Pathway Sphingolipid Metabolism
Galactose Metabolism
Reactome Glycosphingolipid metabolism
WikiPathways Sphingolipid metabolism
References
Ref 551364Identification of the glycosidase inhibitors swainsonine and calystegine B2 in Weir vine (Ipomoea sp. Q6 [aff. calobra]) and correlation with toxicity. J Nat Prod. 1995 Jun;58(6):878-86.
Ref 551364Identification of the glycosidase inhibitors swainsonine and calystegine B2 in Weir vine (Ipomoea sp. Q6 [aff. calobra]) and correlation with toxicity. J Nat Prod. 1995 Jun;58(6):878-86.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.